New England Capital Financial Advisors LLC
Position in MREO — Mereo BioPharma Group plc
CIK 1964652
MERIDEN, CT
Position in MREO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$95
-$4 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 58 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MREO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New England Capital Financial Advisors LLC holds $36,825 across 6 Biotechnology names. MREO ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRPT |
Sarepta Therapeutics, Inc.
|
1,100 | $19,767 | |
| 2 | BHVN |
Biohaven Ltd.
|
1,000 | $14,880 | |
| 3 | VRCA |
Verrica Pharmaceuticals Inc.
|
200 | $1,224 | |
| 4 | HURA |
TuHURA Biosciences, Inc./NV
|
281 | $657 | |
| 5 | HRTX |
Heron Therapeutics, Inc. /De/
|
475 | $202 | |
| 6 | MREO |
Mereo BioPharma Group plc
This page
|
300 | $95 |
All Filings in MREO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95 | 300 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $99 | 300 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $125 | 300 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $618 | 300 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $813 | 300 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $675 | 300 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,050 | 300 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,233 | 300 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,080 | 300 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $990 | 300 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $693 | 300 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $387 | 300 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $396 | 300 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $212 | 300 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $225 | 300 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||